TXMD
TherapeuticsMD, Inc.Company with tickers: TXMD
CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
13F Activity (30d)
35 filings
34 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-12-23 | Thompson Tommy G |
Director | Other | 21 |
| 2025-12-23 | Thompson Tommy G |
Director | Buy | 8,400 |
| 2025-12-23 | Thompson Tommy G |
Director | Other | 14,312 |
| 2025-11-03 | Walker Marlan D |
Chief Executive Officer | Award | 67,492 |
| 2025-11-03 | Naughton Gail K |
Director | Award | 8,500 |
| 2025-11-03 | Thompson Tommy G |
Director | Award | 8,500 |
| 2025-11-03 | Collins Cooper C. |
Director | Award | 8,500 |
| 2025-04-14 | Thompson Tommy G |
Director | Other | 21 |
| 2025-04-14 | Walker Marlan D |
Chief Executive Officer | Buy | 490 |
| 2025-04-14 | Thompson Tommy G |
Director | Other | 14,312 |
| 2025-04-14 | Thompson Tommy G |
Director | Buy | 325 |
| 2025-04-10 | Walker Marlan D |
Chief Executive Officer | Buy | 1,167 |
| 2025-04-09 | Walker Marlan D |
Chief Executive Officer | Buy | 1,136 |
| 2025-02-18 | Collins Cooper C. |
Director | Convert | 8,500 |
| 2025-02-18 | Thompson Tommy G |
Director | Other | 21 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 2,311 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 2,311 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 1,733 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 770 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 3,467 |
| 2025-02-18 | Thompson Tommy G |
Director | Other | 14,312 |
| 2025-02-18 | Naughton Gail K |
Director | Convert | 8,500 |
| 2025-02-18 | Thompson Tommy G |
Director | Convert | 8,500 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 1,733 |
| 2025-02-18 | Collins Cooper C. |
Director | Convert | 8,500 |
| 2025-02-18 | Naughton Gail K |
Director | Convert | 8,500 |
| 2025-02-18 | Thompson Tommy G |
Director | Convert | 8,500 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 770 |
| 2025-02-18 | Walker Marlan D |
Chief Executive Officer | Convert | 3,467 |
| 2024-08-22 | Collins Cooper C. |
Director | Buy | 4,094 |
| 2024-08-21 | Collins Cooper C. |
Director | Buy | 1,200 |
| 2023-12-07 | Walker Marlan D |
Chief Executive Officer | Sell | 4,550 |
| 2023-12-06 | Walker Marlan D |
Chief Executive Officer | Sell | 14,500 |
| 2023-12-05 | Walker Marlan D |
Chief Executive Officer | Convert | 70,000 |
| 2023-12-05 | Walker Marlan D |
Chief Executive Officer | Convert | 70,000 |
| 2023-11-15 | Rubric Capital Management LP |
10% Owner | Award | 877,192 |
| 2023-08-17 | ZIEGLER JOSEPH |
Principal Financial Officer | Other | 0 |
| 2023-08-17 | ZIEGLER JOSEPH |
Principal Financial Officer | Award | 7,500 |
| 2023-07-17 | Thompson Tommy G |
Director | Award | 8,500 |
| 2023-07-17 | Collins Cooper C. |
Director | Award | 8,500 |
| 2023-07-17 | Naughton Gail K |
Director | Award | 8,500 |
| 2023-06-28 | Rubric Capital Management LP |
10% Owner | Award | 312,525 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Convert | 1,010 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Convert | 3,030 |
| 2023-04-12 | Donegan Michael C |
Prin. Fin. and Acctg. Officer | Convert | 50,000 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Convert | 3,030 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Convert | 1,734 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Convert | 1,010 |
| 2023-04-12 | Walker Marlan D |
Chief Executive Officer | Sell | 1,170 |
| 2023-04-12 | Donegan Michael C |
Prin. Fin. and Acctg. Officer | Convert | 50,000 |
Showing 1–50 of 318 transactions